id93
Vaccineexperimental
Clinical trial activity
9 trials · 14 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2012 (NCT01599897)
Timeline
Indications
Mechanism of action
- Mycobacterium tuberculosisImmunity, active
Mycobacterium tuberculosis immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- id93
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06670755 | N/A | Nov 30, 2024 | University of Oxford |
| NCT06205589 | Phase 2 | Oct 15, 2024 | Aurum Institute, National Institute of Allergy and Infectious Diseases (NIAID), University of Washington |
| NCT03806699 | Phase 1 | Apr 2, 2019 | Quratis Inc. |
| NCT03722472 | Phase 1 | Oct 2, 2018 | Immune Design, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) |
| NCT03806686 | Phase 2 | May 31, 2018 | Immune Design, Quratis Inc. |
| NCT02508376 | Phase 1 | Oct 22, 2015 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT02465216 | Phase 2 | Jun 1, 2015 | Infectious Disease Research Institute, South African Tuberculosis Vaccine Initiative (SATVI), Wellcome Trust |
| NCT01927159 | Phase 1 | Sep 1, 2013 | Aeras, Bill and Melinda Gates Foundation, Infectious Disease Research Institute, SATVI, South African Tuberculosis Vaccine Initiative (SATVI) |
| NCT01599897 | Phase 1 | Aug 1, 2012 | Aeras, Bill and Melinda Gates Foundation, Immune Design, Infectious Disease Research Institute, Paul G. Allen Family Foundation |
Showing 9 of 9 trials
Page 1 / 1
Organizations
Research & Development (14)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Immune Design | For profit | 3 | 1 | 2 | 2012 |
| Infectious Disease Research Institute | Academic/Hospital | 3 | 3 | 2 | 2012 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 3 | 2 | 2 | 2015 |
| Aeras | Academic/Hospital | 2 | 0 | 1 | 2012 |
| Bill and Melinda Gates Foundation | Academic/Hospital | 2 | 0 | 1 | 2012 |
| Quratis Inc. | For profit | 2 | 2 | 2 | 2018 |
| South African Tuberculosis Vaccine Initiative (SATVI) | Academic/Hospital | 2 | 0 | 2 | 2013 |
| Aurum Institute | Academic/Hospital | 1 | 0 | 1 | 2024 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 2018 |
| Paul G. Allen Family Foundation | Academic/Hospital | 1 | 0 | 1 | 2012 |
| SATVI | Academic/Hospital | 1 | 0 | 1 | 2013 |
| University of Oxford | Academic/Hospital | 1 | 1 | 1 | 2024 |
| University of Washington | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Wellcome Trust | Academic/Hospital | 1 | 0 | 1 | 2015 |
14 organizations
Page 1 / 1